索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]Evan Kurniawan,张瑞岩.高龄老年患者冠状动脉介入治疗效果及风险评估[J].国际心血管病杂志,2016,02:79-82.
点击复制

高龄老年患者冠状动脉介入治疗效果及风险评估(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2016年02期
页码:
79-82
栏目:
综述
出版日期:
2016-03-20

文章信息/Info

Title:
-
作者:
Evan Kurniawan; 张瑞岩
200025 上海交通大学医学院附属瑞金医院心内科
Author(s):
-
关键词:
-
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2016.02.005
文献标识码:
-
摘要:
高龄老年冠状动脉粥样硬化性心脏病(冠心病)患者合并疾病多,冠状动脉病变复杂程度高,经皮冠状动脉介入治疗(PCI)并发症的发生率较高。对高龄老年患者PCI进行风险及预后评估非常重要。近年来,随着PCI操作技术及策略的改进,高龄老年患者PCI的成功率提高,相关并发症发生率也有所下降。该文对80岁以上的高龄老年冠心病患者接受PCI的疗效、手术风险、并发症及预后评估作一综述。
Abstract:
-

参考文献/References

[1] Kung HC, Hoyert DL, Xu J,et al. Division of vital statistics. deaths: final data for 2005. National vital statistics reports[J]. Natl Vital Stat Rep,2008,56(10):1-120.
[2] Rosamond W, Flegal K, Friday G,et al. Heart disease and stroke statistics—2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee[J]. Circulation,2007,115(5):e69-e171.
[3] Wennberg DE, Makenka DJ, Sengupta A,et al. Percutaneous transluminal coronary angioplasty in the elderly: epidemiology, clinical risk factors, and in-hospital outcomes. The Northern New England Cardiovascular Disease Study Group[J]. Am Heart J,1999,137(4 Pt 1):639-645.
[4] Batchelor WB, Anstrom KJ, Muhlbaier LH, et al. Contemporary outcome trends in the elderly undergoing percutaneous coronary intervention: results in 7.472 octogenarians[J]. J Am Coll Cardiol,2000,36(3):723-730.
[5] Sangiorgi G, Rumberger JA, Severson A,et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology[J]. J Am Coll Cardiol,1998,31(1):126-133.
[6] TIME Investigators. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease(TIME): a randomised trial[J]. Lancet,2001,358(9286):951-957.
[7] Pfisterer M, Trial of invasive versus medical therapy in elderly patients investigators. Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients(TIME)[J]. Circulation,2004,110(10):1213-1218.
[8] Spertus JA, Salisbury AC, Jones PG,et al. Predictors of quality of life benefit after percutaneous coronary intervention[J]. Circulation,2004,110(25):3789-3794.
[9] Moreno R,Salazar A,Banuelos C,et al. Effectiveness of percutaneous coronary interventions in nonagerian[J]. Am J Cardiol,2004,94(8):1058-1060.
[10] McKellar SH, Brown ML, Frye RL,et al. Comparison of coronary revascularization procedures in octogenarians: a systematic review and meta-analysis[J]. Nat Clin Pract Cardiovasc Med,2008,5(11):738-746.
[11] Weintraub WS, Grau-Sepulveda MV, Weiss JM,et al. Comparative effectiveness of revascularization strategies[J]. N Engl J Med,2012,366(16):1467-1476.
[12] Morice MC, Serruys PW, Kappetein AP, et al. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial[J]. Circulation,2014,129(23):2388-2394.
[13] Conrotto F, Scacciatella P, D'Ascenzo F, et al. Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians(from a Drug-Eluting stent for LefT main Artery registry substudy)[J]. Am J Cardiol,2014,113(12):2007-2012.
[14] Repossini A, Tespili M, Saino A, et al. Hybrid coronary revascularization in 100 patients with multivessel coronary disease[J]. Ann Thorac Surg,2014,98(2):574-581.
[15] Liistro F, Angioli P, Falsini G,et al. Early invasive strategy in elderly patients with non-ST elevation acute coronary syndrome: comparison with younger patients regarding 30 day and long term outcome[J]. Heart,2005,91(10):1284-1288.
[16] Devlin G, Gore J, Elliott J,et al. Management and 6-month outcome in elderly and very elderly patients with high-risk non-Stelevation acute coronary syndromes[J]. Eur Heart J,2008,29(10):1275-1282.
[17] Gharacholou SM, Alexander KP, Chen AY, et al. Implications and reasons for the lack of use of reperfusion therapy in patients with ST-segment elevation myocardial infarction: findings from the CRUSADE initiative[J]. Am Heart J,2010,159(5):757-763.
[18] 李茂巍, 张必利, 郑 兴,等. 高龄冠心病患者PCI后院内死亡危险因素分析[J]. 国际心血管病杂志,2015,42(1):56-58.
[19] Christiansen EC, Wickstrom KK, Henry TD, et al. Comparison of functional recovery following percutaneous coronary intervention for ST elevation myocardial infarction in three age groups(<70, 70 to 79 and≥80 years)[J]. Am J Cardiol,2013,112(3):330-335.
[20] Jurado-Román A, Hernández-Hernández F, García-Tejada J,et al.Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention[J]. Am J Cardiol,2015,115(9):1174-1178.
[21] Tsai TT, Patel UD, Chang TI, et al. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry[J]. JACC Cardiovasc Interv,2014,7(1):1-9.
[22] Liu Y, Liu YH, Chen JY, et al. Safecontrast volumes for preventing contrast-induced nephropathy in elderly patients with relatively normal renal function during percutaneous coronary intervention[J]. Medicine(Baltimore),2015,94(12):e615.
[23] 中华医学会心血管病学分会. 含碘对比剂在心血管疾病中临床应用的专家共识(2012)[J]. 中华心血管病杂志,2013,41(2):94-98.
[24] Kinnaird TD, Stabile E, Mintz GS,et al. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions[J]. Am J Cardiol,2003,92(8):930-935.
[25] Mari D, Mannucci PM, Copoola R,et al. Hypercoagulability in centenarians: the paradox of successful aging[J]. Blood,1995,85(11):3144-3149.
[26] Zahavi J, Jones NA, Leyton J,et al. Enhanced in vivo platelet “release reaction” in old healthy individuals[J]. Thromb Res,1980,17(3-4):329-336.
[27] Terres W, Weber K, Kupper W, et al. Age, cardiovascular risk factors and coronary heart disease as determinants of platelet function in men. A multivariate approach[J]. Thromb Res,1991,62(6):649-661.
[28] Vaughan L, Zurlo F, Ravussin E. Aging and energy expenditure[J]. Am J Clin Nutr,1991,53(4):821-825.
[29] Wiviott SD, Braunwald E, McCabe CH,et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes[J]. N Engl J Med,2007,357(20):2001-2015.
[30] 朱建兵,张俊峰. 冠心病抗栓药物新进展[J]. 国际心血管病杂志,2014,41(3):163-166.
[31] Cannon CP, Harrington RA, James S,et al. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes(PLATO): a randomised double-blind study[J]. Lancet,2010,375(9711):283-293.
[32] Lemesle G, Bonello L, De Labriolle A,et al. Impact of bivalirudin use on in-hospital bleeding and six-months outcomes in octogenarians undergoing percutaneous coronary intervention[J]. Catheter Cardiovasc Interv,2009,74(3):428-435.
[33] Cavender MA, Sabatine MS. Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials[J]. Lancet,2014,384(9943):599-606.
[34] Boersma E, Harrington RA, Moliterno DJ, et al. Platelet glycoprotein Ⅱb/Ⅲa inhibitors in acute coronary syndromes: a meta-analysis of all major randomized clinical trials[J]. Lancet,2002,359(9302):189-198.
[35] Kim SM, Moliterno DJ. Ageless benefits of transradial access for percutaneous coronary revascularization[J]. Catheter Cardiovasc Interv,2015,86(6):973-974.
[36] Koutouzis M, Matejka G, Olivecrona G, et al. Radial vs. femoral approach for primary percutaneous coronary intervention in octogenarians[J]. Cardiovasc Revasc Med,2010,11(2):79-83.
[37] Lee HW, Cha KS, Ahn J, et al. Comparison of transradial and transfemoral coronary intervention in octogenarians with acute myocardial infarction[J]. Int J Cardiol,2016,202:419-424.
[38] Dahdouh Z, Roule V, Dugué AE, et al.Rotational atherectomy for left main coronary artery disease in octogenarians: transradial approach in a tertiary center and literature review[J]. J Interv Cardiol,2013,26(2):173-182.

备注/Memo

备注/Memo:
通信作者:张瑞岩, Email: rjzhangruiyan@aliyun.com
更新日期/Last Update: 2016-03-20